Private Advisor Group’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$106K Hold
38,606
﹤0.01% 2527
2025
Q4
$143K Sell
38,606
-15,000
-28% -$48.5K ﹤0.01% 2445
2025
Q3
$142K Buy
53,606
+13,500
+34% +$26.1K ﹤0.01% 2382
2025
Q2
$39.5K Hold
40,106
﹤0.01% 2361
2025
Q1
$57.8K Buy
40,106
+10,000
+33% +$18.4K ﹤0.01% 2228
2024
Q4
$66.2K Sell
30,106
-164
-0.5% -$383 ﹤0.01% 2205
2024
Q3
$49.9K Buy
30,270
+100
+0.3% +$202 ﹤0.01% 2348
2024
Q2
$67K Buy
30,170
+1,342
+5% +$3.16K ﹤0.01% 2258
2024
Q1
$77.3K Hold
28,828
﹤0.01% 2220
2023
Q4
$86.2K Buy
28,828
+222
+0.8% +$288 ﹤0.01% 2127
2023
Q3
$28K Hold
28,606
﹤0.01% 2076
2023
Q2
$39.8K Buy
+28,606
New +$39.9K ﹤0.01% 1975
2020
Q3
Sell
-1,171
Closed -$60K 2134
2020
Q2
$60K Buy
+1,171
New +$49K ﹤0.01% 1994

Other funds holding ESPR